NKTR - Nektar Therapeu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SLVO (-0.86%) SKIN (0.61%) NVDA (-0.19%) LMND (-3.24%) HEPA (0%) GLBE (4.5%) BHG (-2.49%) ATER (-6.46%)

NKTR - Nektar Therapeutics

$16.51 0.13[0.8%]

15 mins delayed data

People also watch : AZN | JNJ | PFE | NVS | ALKS | ENZN

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$16.38	Open	$16.37
Volume	462.4K	Market Cap	2.986B
Yield		Last Dividend

Day

52 Week

Global Opioid Induced Constipation (OIC)...	07/23/21
The report on Global Opioid Induced Constipation (OIC) Drug Market has been provided by researchers for a detailed understanding of market performance...

Nektar Therapeutics (NKTR): Price Up $0....	07/21/21
This is a reversal of the price action on the previous hour, in which price moved down. The post Nektar Therapeutics (NKTR): Price Up $0.01 (0.06)% Ov...

Gram-Negative Bacterial Infection Market...	06/18/21
Global Gram-Negative Bacterial Infection Market: Snapshot Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially...

Natural Killer Cell Therapy Market by Gr...	06/14/21
QYResearch Published Global Natural Killer Cell Therapy Market Research Report 2020: Industry Growth, Opportunities, Vendors, Shares, Competitive Stra...

Nano-Medical Device Market 2021 Emerging...	06/12/21
Worldwide Nano-Medical Device Market Analysis to 2028 is a specialized and in-depth study of the Nano-Medical Device Market Industry with a focus on t...

Nektar Therapeutics to Participate in Fi...	06/06/21
Nektar Therapeutics'' (Nasdaq: NKTR) senior management is scheduled to participate in a virtual fireside chat at the upcoming Goldman Sachs 42 nd Annu...

Bristol-Myers Squibb Company Consensus ...	05/31/21
Bristol-Myers Squibb Company with ticker code (BMY) have now 17 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The ...

Nektar Therapeutics (NKTR): Price Down $...	05/25/21
If you''re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 100 hour timeframe. The post Nektar Therapeutics ...

Bristol-Myers Squibb Company Consensus ...	05/24/21
Bristol-Myers Squibb Company found using ticker (BMY) have now 17 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. Th...

Nektar Therapeutics (NKTR) Received its ...	05/21/21
After BTIG and Mizuho Securities gave Nektar Therapeutics (NASDAQ: NKTR) a Buy rating last month, the company received another Buy, this time from Th...

Nektar Therapeutics Announces First Publ...	05/19/21
Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of preclinical data in the Journal of Translational Autoimmunity describing NKTR-35...

Nektar Therapeutics'' NKTR-255 shows enc...	05/18/21
No summary available.

Nektar Therapeutics Announces its First ...	05/17/21
-- Results demonstrate NKTR-255''s differentiated pharmacologic profile versus precomplexed IL-15 agonists, supporting its potential as a potent immun...

SVB Leerink Analysts Cut Earnings Estima...	05/12/21
Nektar Therapeutics (NASDAQ:NKTR) Stock analysts at SVB Leerink lowered their Q2 2021 earnings per share estimates for shares of Nektar Therapeutics ...

Nektar Therapeutics (NASDAQ:NKTR) Expect...	05/10/21
Equities analysts expect that Nektar Therapeutics (NASDAQ:NKTR) will post $27.30 million in sales for the current quarter, according to Zacks. Five an...

Nektar Therapeutics Shares Close the Wee...	12/18/20
Nektar Therapeutics shares closed the week 13.3% higher than it did at the end of last week. The stock is currently down 11.8% year-to-date, down 11....

ANALYST RATINGS

2 analyst ratings (Last 3 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $NKTR

Service Name	Trader	% Success
Alpha Swing Trades	Jonathan	68.00 %	Follow
Silent swinger	hasmat	44.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.